VERA
Vera Therapeutics, Inc. · Healthcare · Market cap $2.2B
Insiders sold $4.7M net in the last 90 days ·1 seller, 0 buyers· 5 of 5 sales under Rule 10b5-1 plans· latest Form 4 filed Sep 17, 2026
Insider Buying
$250K
reported purchases (SEC code P)
Insider Selling
$9.0M
reported sales (SEC code S)
Unique Insiders
9
in the rolling window
Latest filing
Sep 17, 2026
Fordyce Marshall
Vera Therapeutics, Inc. (VERA) has 33 SEC Form 4 filings (54 transaction rows) in the rolling window, disclosed by 9 distinct insiders. Most recent filing: Sep 17, 2026.
Inside the rolling window, 9 insiders at Vera Therapeutics, Inc. reported 1 open-market purchase totaling $250K and 18 open-market sales totaling $9.0M. The most active filer is PRESIDENT AND CEO Fordyce Marshall with 7 filings. Insiders have net sold $5.7M over the trailing 6 months. The most recent open-market filing is a sale of 18,500 shares by PRESIDENT AND CEO Fordyce Marshall, dated Sep 15, 2026, worth $685K.
- Industry:Biotechnology
- CEO:Marshall Fordyce
- Employees:361
- HQ:Brisbane, CA, US
- IPO:2021-05-14
| Source | |||||||
|---|---|---|---|---|---|---|---|
| PRESIDENT AND CEO | Sale | 18,500 | $685K | Sep 17 | -12.3% | SEC ↗ | |
| PRESIDENT AND CEO | Sale | 18,500 | $650K | Sep 4 | -16.2% | SEC ↗ | |
| PRESIDENT AND CEO | Sale | 46,250 | $2.0M | Aug 12 | +0.2% | SEC ↗ | |
| PRESIDENT AND CEO | Sale | 18,500 | $702K | Aug 12 | +0.2% | SEC ↗ | |
| PRESIDENT AND CEO | Sale | 18,500 | $680K | Aug 12 | +0.2% | SEC ↗ | |
| PRESIDENT AND CEO | Sale | 22,951 | $1.0M | Apr 15 | — | SEC ↗ | |
Young Joseph RFirst in 3 months | SVP, FINANCE, CHIEF ACCT OFFCR | Sale | 3,117 | $131K | Feb 25 | — | SEC ↗ |
Fordyce MarshallFirst filing | PRESIDENT AND CEO | Sale | 16,925 | $711K | Feb 25 | — | SEC ↗ |
| Chief Regulatory Officer | Sale | 2,187 | $92K | Feb 25 | — | SEC ↗ | |
Brenner RobertFirst filing | Chief Medical Officer | Sale | 2,151 | $90K | Feb 25 | — | SEC ↗ |
Grant SeanFirst filing | CHIEF FINANCIAL OFFICER | Sale | 4,949 | $208K | Feb 25 | — | SEC ↗ |
JOHNSON DAVID LEEFirst filing | Chief Operating Officer | Sale | 2,579 | $108K | Feb 25 | — | SEC ↗ |
Skelton Laurence MatthewFirst filing | Chief Commercial Officer | Sale | 1,582 | $66K | Feb 25 | — | SEC ↗ |
| Chief Regulatory Officer | Sale | 10,000 | $501K | Dec 17 | — | SEC ↗ | |
ENRIGHT PATRICK GFirst filing | Director | Purchase | 5,882 | $250K | Dec 15 | — | SEC ↗ |
| Chief Regulatory Officer | Sale | 10,000 | $453K | Dec 10 | — | SEC ↗ | |
Turner William D.First filing | Chief Regulatory Officer | Sale | 10,000 | $400K | Dec 4 | — | SEC ↗ |
Carter Jason SFirst filing | Chief Legal Officer | Sale | 3,864 | $107K | Nov 25 | — | SEC ↗ |
Young Joseph RFirst filing | SVP, FINANCE, CHIEF ACCT OFFCR | Sale | 15,000 | $436K | Nov 13 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does VERA have?
Vera Therapeutics, Inc. (VERA) has 33 SEC Form 4 filings (54 transaction rows) in the rolling 365-day window, disclosed by 9 distinct insiders. Most recent filing: Sep 17, 2026.
When was the most recent SEC Form 4 filing for VERA?
The most recent Form 4 filing for VERA on Tracefour is dated Sep 17, 2026.
Who is the most active insider at VERA?
The most active SEC Form 4 filer at VERA in the rolling window is PRESIDENT AND CEO Fordyce Marshall, with 7 filings.
What is the net insider flow at VERA over the last 6 months?
Over the trailing 180 days, insiders at VERA have net sold $5.7M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at VERA in the current window?
Inside the rolling window, insiders at VERA bought $250K and sold $9.0M based on SEC Form 4 filings.
Can I get alerts for VERA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Vera Therapeutics, Inc. (VERA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Vera Therapeutics, Inc. is in the Healthcare sector.